Brusatol: A Potent Nrf2 Inhibitor for Cancer Therapy Research

Explore the anticancer potential of Brusatol, a key Nrf2 pathway modulator.

Get a Quote & Sample

Key Advantages of Brusatol

Potent Anticancer Activity

Brusatol demonstrates significant cytotoxicity, with IC50 values below 1 μM against numerous cancer cell lines, showcasing its efficacy in preclinical research.

Nrf2 Pathway Modulation

As a key inhibitor of the Nrf2 pathway, Brusatol offers a targeted approach for cancer treatment strategies, influencing cellular defense mechanisms.

Adjuvant Therapy Potential

The compound's ability to enhance chemotherapy efficacy positions it as a valuable agent for adjuvant cancer therapy.

Key Applications

Cancer Research

Investigating the Brusatol cytotoxicity mechanism in various cancer models provides crucial insights into its therapeutic potential.

Drug Discovery

As a novel Nrf2 inhibitor, Brusatol serves as a valuable tool in the development of new anticancer agents.

Ophthalmology Research

Studies exploring Brusatol retinopathy of prematurity research indicate its potential in treating certain ocular conditions.

Biochemical Assays

Brusatol is utilized in assays to understand the intricate workings of the Nrf2 pathway and its role in cellular processes.